Alprazolam Reduces Freezing of Gait (FOG) and Improves FOG-Related Gait Deficiencies

Figure 3

Alprazolam reduces stride time variability while walking in an anxiety-inducing virtual environment. No significant main effect of medication was observed, but there was a significant main effect of condition () and condition × medication interaction (). Paired samples t-test between HA-plank conditions showed significant reduction of stride time variability on alprazolam compared to placebo (t = −2.72, ). Error bars represent the standard error of the mean (SEM).